Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Hyster-Yale, Inc. (HY)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04
$26.95-10.23%
Close 2026-11-05 · 1-day change
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.47 → 1.47 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for HY yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
keep capital expenditures between $55 million and $70 million in 2026 | Capital spending will stay between $55 million and $70 million. | Under Pressure | capex exceeds $70 million or falls below $50 million in FY26 | Capital expenditures: $14.7M FY2026-Q2; GAAP. Published target: capex between 55 and 70 million USD by 2026-12-31. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 202614,700,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a loss-making recovery story, not yet a proven durable compounder. The long-term thesis is in a watch state: revenue and operating losses improved sequentially, but the company still expects a moderate operating loss for 2026.
HY is described as cheap versus peers, while the expectations gap is negative, meaning expectations appear demanding relative to the model’s view. Model confidence is low, so the valuation signal is uncertain; the evidence says pricing is justified rather than unusually fragile.
Near term, the business has shown sequential improvement, with revenue rising and the operating loss narrowing from the first quarter to the second quarter of 2026. Management expects a stronger second half, but reported savings are not yet established, and weak recent performance, a sector headwind, and a decline in company momentum temper the case. A CEO transition adds uncertainty, while an earnings guidance cut would be a meaningful risk.
The multi-year thesis depends on HY delivering the expected second-half recovery, turning cost actions into realized savings, and moving toward profitable growth. Near-term sector direction also matters: continued strength among GEV, PH, and EMR could support the industrials backdrop, while misses or lower guidance could remove that support.
Over the next one to three years, HY’s recovery case has some evidence of sequential progress, but profitability remains unproven and execution risk is elevated. The thesis hinges on sustained improvement and realized cost savings. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
achieve modest full-year operating profit in 2026 |
| Hyster-Yale aims for a modest profit in 2026 despite losses. |
| Broken |
| operating income remains negative through FY26 |
Operating income: $-18.4M FY2026-Q2; GAAP. Published target: modest positive operating income by 2026-12-31. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 2026-18,400,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
grow revenue to about $4.1 billion in 2026 | Revenue should reach about $4.1 billion this year. | Intact | revenue falls below $3.8 billion in FY26 | Revenue: $812.9M FY2026-Q2; GAAP. Published target: revenue ~4118.3 million USD by 2026-12-31. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 2026812,900,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.51 → $1.47 · observed estimates
$3.85B → $3.76B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.51 | $3,851,410,000 | 2 / 2 |
| 2026-07-25 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-07-26 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-07-27 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-07-28 | $1.51 | $3,851,410,000 | 2 / 2 |
| 2026-07-29 | $1.51 | $3,851,410,000 | 2 / 2 |
| 2026-07-30 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-07-31 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-08-01 | $1.51 | $3,851,410,000 | 2 / 2 |
| 2026-08-02 | $1.51 | $3,851,410,000 | 2 / 2 |
| 2026-08-03 | $1.51 | $3,851,410,000 | 2 / 2 |
| 2026-08-04 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-08-05 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-08-06 | $2.07 | $3,851,410,000 | 2 / 2 |
| 2026-08-07 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-08 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-09 | $2.07 | $3,763,495,000 | 2 / 2 |
| 2026-08-10 | $2.07 | $3,763,495,000 | 2 / 2 |
| 2026-08-12 | $2.06 | $3,763,495,000 | 2 / 2 |
| 2026-08-13 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-14 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-15 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-16 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-17 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-18 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-19 | $1.85 | $3,860,495,000 | 2 / 2 |
| 2026-08-20 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-21 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-22 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-23 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-24 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-25 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-26 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-27 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-28 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-29 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-30 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-08-31 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-01 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-02 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-03 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-04 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-05 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-06 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-07 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-08 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-09 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-10 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-11 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-12 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-13 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-14 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-15 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-16 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-17 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-18 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-19 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-20 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-21 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-22 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-23 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-24 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-25 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-26 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-27 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-28 | $1.47 | $3,763,495,000 | 2 / 2 |
| 2026-09-29 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-09-30 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-01 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-02 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-03 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-04 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-05 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-06 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-07 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-08 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-09 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-10 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-11 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-12 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-13 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-14 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-15 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-16 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-17 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-18 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-19 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-20 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-21 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-22 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-23 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-24 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-25 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-26 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-27 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-28 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-29 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-30 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-10-31 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-11-01 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-11-02 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-11-03 | $1.47 | $3,763,445,000 | 2 / 2 |
| 2026-11-04 | $1.47 | $3,763,445,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.